opipramol has been researched along with citalopram in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Holoubek, G; Müller, WE | 1 |
2 other study(ies) available for opipramol and citalopram
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Specific modulation of sigma binding sites by the anxiolytic drug opipramol.
Topics: Adrenergic Uptake Inhibitors; Animals; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Brain; Cell Membrane; Citalopram; Imipramine; Male; Morpholines; Opipramol; Rats; Rats, Sprague-Dawley; Reboxetine; Receptors, Adrenergic, beta; Receptors, Serotonin, 5-HT2; Receptors, sigma; Swimming | 2003 |